“Effective and Rapid Osteoclast Inhibition by Denosumab, is Reflected in Serum C Telopeptide (CTX), Across Different Tumor Types”, J. Anal. Oncol., vol. 2, no. 2, pp.  58–61, Apr. 2013, doi: 10.6000/1927-7229.2013.02.02.1.